D-Wave Quantum: A 21% Revenue Gain, a 19% Bookings Slip and Two Cut Price Targets
Published on 11/22/2026 at 15:32 | Editorial boerse-global.deD-Wave Quantum shares fell 11% on Friday, caught in a broad selloff that also dragged down IonQ, Rigetti and much of the technology and AI complex. The drop raises a question that goes beyond the trading session itself: how much weight can a growth story carry when revenue, bookings and losses are telling different stories at the same time?
Judging the stock means judging both the company and the yardsticks its peers are measured against. The two belong together, but they are not the same thing — and the distinction matters more than usual right now.
Two Analysts, Two Lower Targets, One Unchanged Rating
StoneX weighed in on November 11, with analyst Gary cutting his price target to $20 from $30 while keeping a Buy rating. He cited lower valuations across the peer group and September-quarter results that came in below consensus estimates. The combination is telling: the positive recommendation survived the re-rating, the target did not. A constructive view of the business offers no protection against an analyst lowering the benchmark he measures it by.
Rosenblatt Securities moved the same day. Analyst John McPeake trimmed his target to $30 from $43, also maintaining a Buy. He pointed to the timing of system revenue and a slower ramp in the quantum-computing services business. That reading leaves room for commercial opportunities to convert into revenue later than previously expected — though it is not confirmation that such an acceleration has already begun.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Revenue and Bookings Pull in Opposite Directions
D-Wave reported third-quarter 2026 revenue of $4.5 million, up 21% year over year. Growth, then, is real. What complicates the picture is what happened alongside it.
Quarterly bookings came in at $1.9 million, roughly 19% below the year-earlier figure. Higher revenue did not come with higher bookings in the same quarter. That divergence is the central soft spot: rising top-line receipts alone do not prove matching momentum in newly won business.
The longer reporting period tells a different story. Bookings for the first nine months of 2026 reached $37.4 million, a gain of 611% over the prior-year period. That surge belongs in any fair assessment — but it is a counterweight, not a substitute for examining the losses.
The Loss Line Sets the Limits
D-Wave posted a net loss of $48.2 million, with an adjusted EBITDA loss of $37.7 million. Against that backdrop, simply extrapolating revenue growth is not enough for a more favorable reading. Investors also need to ask whether additional business improves the loss trajectory. If bookings stay weak and the ramp runs slower, the expected operating relief could slip further into the future.
A legal risk adds to the pile. Pomerantz LLP announced a securities class action against D-Wave and certain executives on November 17, alleging misleading statements about operational and financial development and about growth. These are allegations, not judicially established violations.
D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.
What Would Tip the Balance
One data point arrived on November 12, when Gartner classified D-Wave as a "Market Shaper" in quantum computing. For the bull case to hold, that recognition would need to show up in additional business wins. Stronger bookings combined with more reliable revenue conversion would improve the operating footing for a potential share-price recovery. The Gartner designation on its own does not replace that economic proof.
The sequence for investors is fairly clear. First comes the development of new business signings. Then the question of when those translate into revenue, and how losses move in the process. A single stronger revenue period could build confidence, but without an improvement in bookings its signal for the road ahead stays limited.
The next concrete date is December 15, the lead-plaintiff deadline Pomerantz cited. It concerns the litigation, not commercial progress. The more important catalyst for any investment case remains hard evidence of fresh demand: additional bookings that subsequently turn into revenue.
Ad
D-Wave Quantum Stock: New Analysis - 22 November
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
